Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-24T20:17:01.478Z Has data issue: false hasContentIssue false

Chapter 21 - Cardioversion-related stroke

from Section VII - Other uncommon causes of iatrogenic stroke

Published online by Cambridge University Press:  20 October 2016

By
Morten L. Hansen  and
Steen Husted
Edited by
Alexander Tsiskaridze ,
Arne Lindgren  and
Adnan I. Qureshi
Alexander Tsiskaridze
Affiliation:
Sarajishvili Institute of Neurology, Tblisi State University, Georgia
Arne Lindgren
Affiliation:
Department of Neurology, University Hospital Lund, Sweden
Adnan I. Qureshi
Affiliation:
Department of Neurology, University of Minnesota
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Treatment-Related Stroke
Including Iatrogenic and In-Hospital Strokes
 , pp. 222 - 226
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Watson, T, Shantsila, E, Lip, G Y. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet. 2009; 373(9658):155–66.Google Scholar
Manning, W J, et al. Impaired left atrial mechanical function after cardioversion: Relation to the duration of atrial fibrillation. J Am Coll Cardiol. 1994; 23(7):1535–40.Google Scholar
O’Neill, P G, et al. Return of atrial mechanical function following electrical conversion of atrial dysrhythmias. Am Heart J. 1990; 120(2):353–9.Google Scholar
Shapiro, E P, et al. Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol. 1988; 62(17):1202–7.CrossRefGoogle ScholarPubMed
Ikram, H, Nixon, PG, Arcan, T. Left atrial function after electrical conversion to sinus rhythm. Br Heart J. 1968; 30(1):80–3.Google Scholar
Manning, W J, et al. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol. 1989; 13(3):617–23.Google Scholar
Grimm, R A, et al. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: Characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol. 1993; 22(5):1359–66.Google Scholar
Black, I W, et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation. 1994; 89(6):2509–13.Google Scholar
Black, I W, et al. Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am Heart J. 1993; 126(2):375–81.CrossRefGoogle ScholarPubMed
Missault, L, et al. Embolic stroke after unanticoagulated cardioversion despite prior exclusion of atrial thrombi by transoesophageal echocardiography. Eur Heart J. 1994; 15(9):1279–80.Google Scholar
Bjerkelund, C J, Orning, O M. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol. 1969; 23(2):208–16.Google Scholar
Lown, B. Electrical reversion of cardiac arrhythmias. Br Heart J. 1967; 29(4):469–89.Google Scholar
Oram, S, Davies, J P. Further experience of electrical conversion of atrial fibrillation to sinus rhythm: Analysis of 100 patients. Lancet. 1964; 1(7346):1294–8.Google Scholar
Resnekov, L, McDonald, L. Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion. Br Heart J. 1967; 29(6):926–36.Google Scholar
McCarthy, C, Varghese, P J, Barritt, D W. Prognosis of atrial arrhythmias treated by electrical counter shock therapy. A three-year follow-up. Br Heart J. 1969; 31(4):496–500.Google Scholar
Berger, M, Schweitzer, P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: A retrospective analysis. Am J Cardiol. 1998; 82(12):1545–7.Google Scholar
Gallagher, M M, et al. Embolic complications of direct current cardioversion of atrial arrhythmias: Association with low intensity of anticoagulation at the time of cardioversion. J Am Coll Cardiol. 2002; 40(5):926–33.CrossRefGoogle ScholarPubMed
Arnold, A Z, et al. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol. 1992; 19(4):851–5.Google Scholar
Collins, L J, et al. Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation. 1995; 92(2):160–3.Google Scholar
Israel, C W, et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol. 2004; 43(1):47–52.Google Scholar
Camm, A J, et al. focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012; 33(21):2719–47.Google Scholar
Camm, A J, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010; 31(19):2369–429.Google Scholar
www.uptodate.com/contents/warfarin-drug-information?source=see_link. [Accessed September 27, 2015].Google Scholar
Connolly, S J, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361(12):1139–51.Google Scholar
www.uptodate.com/contents/warfarin-drug-information?source=see_link. [Accessed September 27, 2015].Google Scholar
Nagarakanti, R, et al. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion. Circulation. 2011; 123(2):131–6.Google Scholar
www.uptodate.com/contents/warfarin-drug-information?source=see_link. [Accessed on September 27, 2015].Google Scholar
www.uptodate.com/contents/warfarin-drug-information?source=see_link. [Accessed September 27, 2015].Google Scholar
Granger, C B, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011; 365:981–92.Google Scholar
Flaker, G, et al. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: Insights from the ARISTOTLE trial (apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation). Journal of the American College of Cardiology. 2014; 63:1082–7.Google Scholar
Patel, M R, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011; 365:883–91.Google Scholar
Cappato, R, et al. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation. European Heart Journal. 2014; 35:3346–55.Google Scholar
www.uptodate.com/contents/warfarin-drug-information?source=see_link. [Accessed September 27, 2015].Google Scholar
Weigner, M J, et al. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med. 1997; 126:615–20.Google Scholar
Stoddard, M F, et al. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. Am Heart J. 1995; 129(6):1204–15.Google Scholar
Stoddard, M F, et al. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study. J Am Coll Cardiol. 1995; 25(2):452–9.Google Scholar
Klein, A L, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 2001; 344(19):1411–20.Google Scholar
Weigner, M J, et al. Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: Short-term safety and impact on maintenance of sinus rhythm at 1 year. Am J Med. 2001; 110(9):694–702.Google Scholar
Camm, A J, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010; 12(10):1360–420.Google Scholar
www.uptodate.com/contents/warfarin-drug-information?source=see_link. [Accessed September 27, 2015].Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×